Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | IS2 - Invited Science: Headache

Monday 04/04/22
01:00 PM - 03:00 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Invited Science
Headache
This session will highlight cutting edge science of hot topics in headache in partnership with the American Headache Society.
2.00 CME credits

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:15 PM PDT Speaker Amylin Induces Migraine-Like Behaviors in Mice
Levi P. Sowers, PhD
01:00 PM - 01:00 PM PDT Speaker walk in slides
Rebecca E. Wells, MD, FAAN
01:15 PM - 01:20 PM PDT Q&A Questions and Answers
Levi P. Sowers, PhD
01:20 PM - 01:35 PM PDT Speaker Disconnectome of the Migraine Brain: A Model of Migraine as “Connectopathy”
Antonio Russo, Prof
01:35 PM - 01:40 PM PDT Q&A Questions and Answers
Antonio Russo, Prof
01:40 PM - 01:55 PM PDT Speaker Neuronal Complexity is Attenuated in Chronic Migraine and Restored by HDAC6 Inhibition
Amynah Pradhan, PhD
01:55 PM - 02:00 PM PDT Q&A Questions and Answers
Amynah Pradhan, PhD
02:00 PM - 02:15 PM PDT Speaker Effectiveness of Mindfulness Meditation vs. Headache Education for Adults With Migraine: A Randomized Clinical Trial
Rebecca E. Wells, MD, FAAN
02:15 PM - 02:20 PM PDT Q&A Questions and Answers
Rebecca E. Wells, MD, FAAN
02:20 PM - 02:35 PM PDT Speaker PACAP-induced Cephalic Allodynia is Inhibited by Delta Opioid Receptor Activation
Elizaveta Mangutov
02:35 PM - 02:40 PM PDT Q&A Questions and Answers
Elizaveta Mangutov
02:40 PM - 02:55 PM PDT Speaker White Matter Hyperintensities in Patients with Migraine
Catherine Daniela Chong, PhD, FAAN
02:55 PM - 03:00 PM PDT Q&A Questions and Answers
Catherine Daniela Chong, PhD, FAAN
Faculty Disclosures
Levi P. Sowers, PhD Levi P. Sowers, PhD has nothing to disclose.
Amynah Pradhan, PhD The institution of Amynah Pradhan, PhD has received research support from Lundbeck.
Rebecca E. Wells, MD, FAAN The institution of Dr. Wells has received research support from NIH. The institution of Dr. Wells has received research support from National Headache Foundation. Dr. Wells has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Practicing Clinician Exchange 2019 Symposia Series 1. Dr. Wells has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Southern Headache Society. Dr. Wells has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Headache Cooperative of New England. Dr. Wells has received personal compensation in the range of $500-$4,999 for serving as a Speaker with WebMD. Dr. Wells has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Wells has received personal compensation in the range of $0-$499 for serving as a Patient Education Day Speaker, Mindfulness Speaker with Miles for Migraine.
Elizaveta Mangutov Elizaveta Mangutov has nothing to disclose.
Antonio Russo, Prof No disclosure on file
Catherine Daniela Chong, PhD, FAAN Dr. Chong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HCOP. The institution of Dr. Chong has received research support from AMGEN. The institution of Dr. Chong has received research support from Department of Defense. The institution of Dr. Chong has received research support from NIH. An immediate family member of Dr. Chong has received intellectual property interests from a discovery or technology relating to health care.
Peter Goadsby, MD, PhD, FRS Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli-Lilly. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aurene. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tremeau. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon Biopharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from Celgene. The institution of Dr. Goadsby has received research support from NIHR. The institution of Dr. Goadsby has received research support from Kallyope. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Executive roles with American Headache Society that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Director with American Migraine Foundation that is relevant to AAN interests or activities.
Nina Yakovlevna Riggins, MD, FAAN Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Gerson Lehrman Group . Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeurologyLive. The institution of Dr. Riggins has received research support from ElectroCore (GammaCore). The institution of Dr. Riggins has received research support from Miles for Migraine. The institution of Dr. Riggins has received research support from Eli Lilly. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has a non-compensated relationship as a PI on research study with TheraSpecs that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Advisory Board with NeurologyLive that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Member of the Board with Miles for Migraine that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI in the study which used sphenocath device with Dolor Technologies that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI with Theranica that is relevant to AAN interests or activities.